Medical Tablets

Ledipasvir & Sofosbuvir Tablets is an anti-cancer medication containing the drug Ledipasvir & Sofosbuvir Tablets which is an inhibitor and interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells, where there is uncontrolled cell growth. It is used in the treatment of non-small lung cancer cells. It is also used in other lines of treatment for patients with EGFR mutations.

Sofosbuvir Tablets efficacy has been established in subjects with HCV genotype 1, 2, 3 or 4 infection, including those with hepatocellular carcinoma meeting Milan criteria (awaiting liver transplantation) and those with HCV/HIV-1 co-infection. This one is the first drug that has demonstrated safety and efficacy to treat certain types of HCV infection without the need for co-administration of .

Features:

• Absorbed with ease
• Non-irritant
• Treats HCV infection

Hepcvir L Tablets is the first once-a-day, fixed dose oral combination therapy that has been approved for chronic hepatitis C genotype 1 patients. This one is a prescription drug and should be used under proper medical guidance and advice. This drug can be use of as a combination therapy with other medicine and successfully administered for genotypes 1, 2, 3, and 4.

Features:

• Easily absorbed
• Non-irritating to the skin
• Anti-virus properties

Tamoxifen is an antagonist of the estrogen receptor in tissue Tamoxifen Tablets. It has been the standard endocrine (anti-estrogen) therapy for hormone-positive early cancer, although aromatase inhibitors have been proposed for postmenopausal women.